Top compounds associated with response to LDHD


Feature Type Standardized
Nominal ANOVA
mRNA niclosamide CTRPv2 pan-cancer AAC -0.016 0.7
mRNA lapatinib gCSI pan-cancer AAC 0.023 0.7
mRNA nelarabine CTRPv2 pan-cancer AAC -0.017 0.7
mRNA PLX4720 CCLE pan-cancer AAC -0.019 0.7
mRNA Gemcitabine CTRPv2 pan-cancer AAC 0.014 0.7
mRNA tivantinib CTRPv2 pan-cancer AAC 0.019 0.7
mRNA MG-132 GDSC1000 pan-cancer AAC 0.021 0.7
mRNA Bleomycin CTRPv2 pan-cancer AAC -0.016 0.7
mRNA MS-275 CTRPv2 pan-cancer AAC 0.014 0.7
mRNA LY-2183240 CTRPv2 pan-cancer AAC -0.013 0.7
Download CSV